Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.
Epistemonikos ID: 76e7307dec6b5046a9bad02ce0e53eea997b09fd
First added on: May 21, 2024